bifidobacterium oor Fins
bifidobacterium
en
Any bacterium of the genus Bifidobacterium
Vertalings in die woordeboek Engels - Fins
bifidobakteeri
en
bacterium of the genus Bifidobacterium
Combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum)
Bifidobakteerien (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) yhdistelmä
Geskatte vertalings
Vertoon algoritmies gegenereerde vertalings
Prenteboek
voorbeelde
Advanced filtering
Voorbeelde moet herlaai word.
The assessment of the preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Lisäksi tehokas toiminta vaatii huomattavia resursseja kuljetusketjun eriytettyyn verkkoon kytkeytymistä vartenEurLex-2 EurLex-2
Bifidobacterium strains
Haluan puhua hänen kanssaantmClass tmClass
Galacto-oligosaccharide is produced from milk lactose by an enzymatic process using β-galactosidases from Aspergillus oryzae, Bifidobacterium bifidum, Pichia pastoris, Sporobolomyces singularis, Kluyveromyces lactis, Bacillus circulans, and Papiliotrema terrestris .
Ilmavaivat Suukipu Ummetus Kielikipu Suun kuivuminen Gastroeso-fageaalinen refluksitautiEuroParl2021 EuroParl2021
Following an application from Töpfer GmbH, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of a combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) on decreasing potentially pathogenic intestinal micro-organisms (Question No EFSA-Q-2009-00224) (6).
Haluan vain istua aikaniEurLex-2 EurLex-2
Viable cells of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351, and Enterococcus faecium DSM 21913
Minä pidän siitäEurLex-2 EurLex-2
On 5 May 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing gastro-intestinal discomfort.
Presidentti ja varapresidentti on kuljetettu erillisiin kohteisiinEurLex-2 EurLex-2
(2) Commission Implementing Regulation (EU) No 544/2013 of 14 June 2013 concerning the authorisation of a preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 as a feed additive for chickens for fattening (holder of authorisation Biomin GmbH) (OJ L 163, 15.6.2013, p.
Portugalin mukaan kyseessä on Cordexin ensimmäinen kansainvälistymishanke, eikä yrityksellä ole aiempaa kokemusta Brasilian markkinoiltaEurLex-2 EurLex-2
The application concerns the authorisation of a preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 as a feed additive for chickens for fattening, to be classified in the additive category ‘zootechnical additives’.
Tiesitkö, että tytön ensimmäinen kerta on hyvin tärkeäEurLex-2 EurLex-2
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 9 December 2014 (3) that, under the proposed conditions of use, the preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 does not have an adverse effect on animal health, human health and the environment and has the potential to be efficacious when used in chickens reared for laying and minor poultry species other than laying.
Saanko polttaa?EurLex-2 EurLex-2
In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for a new use of a preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 and for an amendment of the terms of the current authorisation for chickens for fattening granted by Commission Implementing Regulation (EU) No 544/2013 (2).
Jäsenvaltioiden olisi otettava tämän suosituksen toteuttamisessa huomioon yhtiömuotoisten yhteissijoitusyritysten erityispiirteet ja vältettävä oikeudelliselta muodoltaan erilaisten yhteissijoitusyritysten tarpeetonta eriarvoista kohteluaEurLex-2 EurLex-2
In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of a preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913.
varmistamalla kuluttajille korkeatasoinen suoja heidän asioidessaan palvelujen tarjoajien kanssa erityisesti siten, että käytettävissä on yksinkertaisia ja kustannuksiltaan edullisia riitojenratkaisumenettelyjä, joista vastaa asianomaisista osapuolista riippumaton elinEurLex-2 EurLex-2
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 14 November 2012 ( 2 ) that, under the proposed conditions of use, the preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 does not have an adverse effect on animal health, human health or the environment, and that it has the potential to improve the performance of chickens for fattening.
Katsele ympärillesiEurLex-2 EurLex-2
– in Case C‐211/03: ‘Lactobact omni FOS’ (in powder form, one gram of the powder containing at least 1 000 000 000 organisms from the following six bacterial strains: Lactobacillus acidophilus, Lactococcus lactis, E. faecium, Bifidobacterium bifidum, Lactobacillus casei, and Lactobacillus thermophilus.
Aihe: Eurooppa-koulujen oppilasvalinta lukuvuonnaEurLex-2 EurLex-2
The assessment of the preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Niin selitit, mutta me emme ymmärräEurLex-2 EurLex-2
Galacto-oligosaccharide is produced from milk lactose by an enzymatic process using β-galactosidases from Aspergillus oryzae, Bifidobacterium bifidum and Bacillus circulans.
Tiesin voivani luottaa sinuuneurlex-diff-2018-06-20 eurlex-diff-2018-06-20
Bulgaricus, Lactococcus lactis ssp., Leuconostoc mesenteroides, Streptococcus thermophilus, Lactobacillus spp, or Bifidobacterium spp., containing not less than 44 % Nitrogen expressed as crude protein.
Suola ruostuttaa metalliaEurLex-2 EurLex-2
Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913
Saimme joitakin epätavallisia tuloksia verikokeestasiEurLex-2 EurLex-2
32013 R 0544: Commission Implementing Regulation (EU) No 544/2013 of 14 June 2013 concerning the authorisation of a preparation of Bifidobacterium animalis ssp. animalis DSM 16284, Lactobacillus salivarius ssp. salivarius DSM 16351 and Enterococcus faecium DSM 21913 as a feed additive for chickens for fattening (holder of authorisation Biomin GmbH) (OJ L 163, 15.6.2013, p.
Tuollaista röyhtäisyä en kyllä ole kuullutEurLex-2 EurLex-2
76 sinne gevind in 7 ms. Hulle kom uit baie bronne en word nie nagegaan nie.